Eve Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 6.6/10
Best for: moving between compounded and brand without changing seller
Eve falls below our bar on disclosure. Its compounded tirzepatide costs $195 a month, 28% below the $269 median among the sellers we compare.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Covered by the monthly price
Medication
In the price
Clinician visits
In the price
Shipping
In the price
Lab work
Not stated
Coaching
Not stated
Prices checked June 2026
Eve (Eve Health, Inc.) is a women's-health telehealth brand that sells compounded GLP-1 therapy alongside brand Ozempic, Wegovy and Mounjaro. It shows no prices before the intake quiz and says you pay $0 unless a physician approves you. The last published figures were $195/mo compounded and $1,399 to $1,699/mo for brand pens.
Is Eve legit?
Yes. Eve is a real, operating US company, and we found no FDA warning letters issued to it. We rate it 6.6/10 overall, across six areas from price to trust and safety. Legitimate is not the same as right for you, though: that part is a decision for you and a licensed clinician.
Is there an Eve promo or coupon code?
Eve has no code to type in. The current offer: $99 first-month GLP-1 (semaglutide) offer; promo applied via 'semfirst99' embedded in the start-online-visit GLP-1 CTA links. It applies at checkout on its own. Coupon sites advertising an "Eve promo code" are not a source we can vouch for.
See how Eve compares on our rankings of the best semaglutide providers and the best tirzepatide providers.
Vetted alternatives to Eve
Embody
Best for: a flat compounded tirzepatide or semaglutide price at every dose, from a seller that names its pharmacies
Editorial score · methodology
Collective
Best for: flat any-dose pricing, if you can absorb a $199 annual membership on top
Editorial score · methodology
AgelessRx
Best for: microdosed compounded GLP-1s from a longevity clinic, or brand Wegovy at manufacturer pricing plus monitoring
Editorial score · methodology
Eve at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide, Wegovy, Ozempic, Mounjaro
- Starting price
- $195/mo
- What's included
- Medication · Consult · Shipping
- FDA status
- No FDA warning letters found
How Eve scores
Six columns, each one computed from something Eve has published rather than from an opinion we formed: what it charges, which molecules it will dispense, what its record shows, and what the monthly figure actually buys. Where a seller keeps something back, such as its price or its pharmacy, the score reflects it. Every seller we review goes through the same six columns.
Value25%
7.3/10$195/month is 28% below the $269 median for compounded tirzepatide across the sellers we compare.
Effectiveness25%
10.0/10Dispenses semaglutide and tirzepatide, including the FDA-approved product. Anchored to SURMOUNT-1 (tirzepatide, -20.9%) and STEP 1 (semaglutide, -14.9%).
User Experience15%
3.0/10No price appears until the medical intake is finished.
Trust & Safety15%
4.0/10No pharmacy is named for its prescriptions. Its price appears only after the medical intake.
Accessibility10%
5.0/10No state list is available to check, so this is held at the midpoint rather than scored on reach.
Support10%
7.0/10The price covers the medication, clinician visits and shipping.
A seller that shows no price until after the medical intake loses points on User Experience and Trust & Safety, and its review says so. How we score →
What we checked on Eve
Last checked October 2026- Checked the listed price across 5 dose or plan tiers
- Checked what the monthly price covers, and what it leaves out
- Checked FDA warning letters for Eve
Price, availability, and compliance here are read off the seller's own pages and off primary regulatory records, named in the sources below.
What signing up with Eve involves
What to expect on the way to a prescription: where the price appears, who fills the medication, and what the monthly price covers. It is not medical advice, and a clinician makes the prescribing decision.
- 1Eve shows a price only after you finish its medical questionnaire, so you cannot compare costs until you have shared health information.
- 2Ask Eve which pharmacy fills the prescription before you pay. The pharmacy's name is what lets you check its license.
- 3The monthly price includes the medication, clinician visits and shipping.
- Lowest ongoing monthly price: semaglutide $195, tirzepatide $195. That leaves out membership fees, first-month rates and insurance copays.
- Confirm that Eve serves your state before you start.
- The medication is compounded, so it is not an FDA-approved product and has not been reviewed by the agency for safety, effectiveness or manufacturing quality.
Cancelling Eve
Taken from the terms Eve publishes. Terms change, so check the current policy before you subscribe.
- Refund policy
- Money-back satisfaction guarantee
Medications Eve lists
Eve lists Wegovy, Ozempic, Mounjaro, compounded semaglutide and compounded tirzepatide. Each one has its own guide: how it works, the dosing schedule, the side effects that show up in practice, and what the trials measured.
Pricing
Prices re-verified
Check the price yourself before you pay
Every figure here comes from Eve's own website, as of the date shown. Sellers move prices without announcing it, and promotional rates lapse, so confirm the standing cost on their site before committing.
In its favor
- Semaglutide costs $195 a month, close to the $199 median for compounded semaglutide across the sellers we compare
- Tirzepatide costs $195 a month, 28% below the $269 median for compounded tirzepatide across the sellers we compare
- The monthly price includes the medication, clinician visits and shipping
- We found no FDA warning letters issued to Eve
Against it
- You only see a price after finishing the medical intake, so you cannot compare costs before sharing health information
- Confirm it serves your state before you start the intake
- Ask which pharmacy fills the prescription before you pay, so you can check its license
- Its compounded semaglutide and tirzepatide are not FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
What Eve charges
Eve lists $195/month. That sits at the affordable end of what we see.
- Compounded semaglutide: $195/month
- Compounded tirzepatide: $195/month
- Ozempic: $1,399/month
- Wegovy: $1,699/month
- Mounjaro: $1,399/month
For compounded tirzepatide, the median across the sellers we compare is $269/month, so Eve's $195 is genuinely below the middle, not just advertised that way. Before you pay, compare Eve's cancellation terms with other sellers' cancellation and refund policies. For scale, the dearest tenth of compounded sellers charges about three times the cheapest tenth.
Belle Health, at about $199/month, is the closest like-for-like alternative we review.
What Eve dispenses
Eve prescribes semaglutide (approved as Wegovy and Ozempic) and tirzepatide (approved as Zepbound and Mounjaro). Between them these are the two best-evidenced weight-loss molecules currently on the market. You can take the approved brand pen or the cheaper compounded preparation. What separates them is review: the approved product went through it, the compounded one did not, and that is the whole of the trade. For what differs besides the price, see compounded semaglutide vs Ozempic and Wegovy.
Safety and disclosure
Before you start an intake, ask Eve which states it serves, which pharmacy fills its prescriptions and what the monthly price includes. We found no FDA warning letters issued to Eve. The pharmacy question matters most here because the medication is compounded. If Eve will not name the pharmacy, treat that as a warning sign. Once you have the pharmacy's name, 503A vs 503B explains which regulator oversees it and how to check. How we weigh oversight, disclosure and price is set out in our scoring methodology.
Who should look elsewhere
- You need insurance to cover the cost. Check whether Eve bills your plan before you start.
It fits if
- the lowest standing monthly cost is what you are solving for
Our read
Eve competes on price: $195/month. The catch is disclosure, which is why Eve scores low on Trust & Safety: settle the pharmacy and pricing questions above before the price decides for you.
The Bottom Line
Eve falls below our bar on disclosure. Its compounded tirzepatide costs $195 a month, 28% below the $269 median among the sellers we compare.
Before you pay Eve
Starting at $195 a month. Check today's price, then start the intake.
Where Eve is the wrong choice
No seller suits every reader, and pretending otherwise is the easiest way to sell one. On these two counts, another seller does better.
- If the standing monthly cost is what decides it, consider WellMedRx (from $49/mo).
- If you want a human checking in, not just a prescription, consider Eden.
If none of these fits, our guide to alternatives to Eve sets more sellers in the same category beside Eve on price, states and what the price includes.
Frequently Asked Questions
How to check Eve yourself
Glossary
The words sellers use, defined. Tap any term.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
Cited across this Eve review: primary regulatory filings, and peer-reviewed studies.
Sources & methodology — as of October 2026
- 1.GLP Watchdog — GLP-1 Pricing Index 2026 (our independent dataset)— GLP Watchdog.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Aronne LJ et al.)— New England Journal of Medicine.PMID: 40353578.
See Eve's current pricing
Plans start at $195 a month. Whether you qualify is a clinician's decision, made after your intake.